Skip to main content

Table 1 Overview of studies investigating the use of procalcitonin in different types and sites of infections

From: Procalcitonin-guided diagnosis and antibiotic stewardship revisited

 

Type of infection

New studies since 2010?

Study design

PCT cut-off (μg/L)

Benefit of PCT use?

Main conclusions

Selected references since 2012

Pulmonary

AECOPD

yes

RCT (N = 120),

meta-analysis

<0.25

++

PCT reduces initiation of antibiotic treatment in the ED without adverse outcomes

[7, 12]

Asthma

yes

RCT (N = 216)

<0.1–0.25

++

PCT reduces initiation of antibiotic treatment in the ED without adverse outcomes

[89]

Bronchitis

yes (Registry)

RCT, real-life (Registry)

<0.1–0.25

++

PCT reduces initiation of antibiotic treatment in the ED without adverse outcomes

[42]

Community-acquired pneumonia

yes

RCT, meta-analysis (N = 4467)

real-life (Registry)

<0.1–0.25; 80–90% decrease

+++

PCT shortens length of antibiotic therapy in the ED and hospital ward without adverse outcomes

[7]

Pulmonary fibrosis

yes

RCT (N = 78)

<0.25

++

PCT reduces initiation of antibiotic treatment in the ED without adverse outcomes

[15]

Upper respiratory tract infections

no

RCT (N = 458, 702)

<0.1–0.25

+++

PCT reduces initiation of antibiotic treatment in primary care without adverse outcomes (non-inferiority)

[90, 91]

Heart

Congestive heart failure

yes

Observational, RCT (secondary analysis, N = 110)

<0.21–0.25

++

PCT helps in identification of bacterial superinfection in acute heart failure, may be helpful in guiding antibiotic treatment

[38, 43]

Endocarditis

no

Observational, meta-analysis

<0.5

+

PCT is a predictor of poor outcome, diagnostic value similar to CRP

[67, 68]

Abdominal

Abdominal infections with peritonitis

yes

Observational

<0.5; 80% decrease

++

PCT-guided therapy was associated with lower antibiotic exposure with no difference in mortality

[66]

Appendicitis

yes

Observational, meta-analysis

NR

+

PCT is a marker of complicated appendicitis, low value for diagnosing appendicitis

[92]

Pancreatitis

yes

RCT (N = 71)

<0.5

++

PCT reduces antibiotic exposure compared to prophylactic antibiotic treatment without adverse outcomes

[65]

Urinary tract infections

yes

RCT (N = 125)

<0.25

++

PCT reduces antibiotic exposure without adverse effects

[47]

Blood

Blood stream infection

yes

Observational

<0.25–1.47

++

PCT levels correlate with risk for positive blood cultures

[19, 27]

Neutropenia

yes

RCT (N = 62)

NR

PCT is not useful to manage antibiotic therapy, but PCT was a marker of bacteremia

[93]

Severe sepsis/shock

yes

RCT (N = 1575)

<0.5; 80% decrease

+++

PCT reduces antibiotic exposure and 3 month mortality in the ICU

[30]

Postoperative

Postoperative abdominal infection

yes

Observational, meta-analysis

NR

+

Low PCT post-surgical ensure safe discharge, PCT is similar to CRP

[58, 59]

Postoperative infections

yes

RCTs, Observational

<0.5–2.0

++

Low PCT suggests absence of perioperative infection and enables early discharge

 

Other

Arthritis

yes

Observational

<0.5

+

PCT identifies infection in patients with rheumatoid arthritis

[94]

Erysipelas

yes

Observational

<0.1

+

PCT differentiates erysipelas from DVT

[81]

Meningitis

no

RCT, meta-analysis (N = 2058)

<0.5

+++

PCT reduces AB treatment during viral outbreak; serum PCT with CSF lactate reliably identifies bacterial meningitis

[72, 74]

  1. Abbreviations: AB antibiotic, AECOPD acute exacerbation of chronic obstructive pulmonary disease, CSF cerebral spinal fluid, CRP C-reactive protein, ED emergency department; ICU intensive care unit; NR not reported, PCT procalcitonin, RCT randomized controlled trial. The level of evidence in favor or against PCT for each infection was rated by two of the coauthors (PS, RSA) independently and disagreements were resolved by consensus. +: moderate evidence in favor of PCT; ++: good evidence in favor of PCT; +++: strong evidence in favor of PCT; –: no evidence in favor of PCT